Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Acumen Pharmaceuticals, Inc. (ABOS) Insider Trading Activity

    Healthcare • Biotechnology • 51 employees

    Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

    Total Value

    -$258,984.54

    Total Shares

    400,934

    Average Trade Value

    -$14,388.03

    Most Active Insider

    O Connell Daniel Joseph

    Total Activity: $107,975

    Largest Single Transaction

    $87,873

    by O Connell Daniel Joseph on Jan 3, 2025

    30-Day Activity

    6 Transactions

    Volume: 55,436 shares
    Value: $91,967

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    CFO Chief Business Officer
    Officer
    Jan 23, 2025 28,902 $49,633 231,744 (-12.5%) Sale
    Chief Medical Officer
    Officer
    Jan 21, 2025 3,219 $5,118 170,298 (-1.9%) Sale
    Chief Executive Officer
    Director, Officer
    Jan 21, 2025 12,619 $20,102 667,488 (-1.9%) Sale
    Chief Legal Officer Corp Sec
    Officer
    Jan 21, 2025 3,418 $5,435 161,127 (-2.1%) Sale
    Chief Operating Officer
    Officer
    Jan 21, 2025 2,914 $4,692 136,117 (-2.1%) Sale
    CFO Chief Business Officer
    Officer
    Jan 21, 2025 4,364 $6,986 260,646 (-1.7%) Sale
    Chief Executive Officer
    Director, Officer
    Jan 7, 2025 225,400 $0 680,107 (+33.1%) Grant
    Chief Legal Officer Corp Sec
    Officer
    Jan 6, 2025 66,800 $0 164,545 (+40.6%) Grant
    Chief Regulatory Officer
    Officer
    Jan 6, 2025 8,800 $0 8,800 (+100.0%) Grant
    President and Cdo
    Officer
    Jan 6, 2025 62,600 $0 62,600 (+100.0%) Grant
    CFO Chief Business Officer
    Officer
    Jan 6, 2025 66,800 $0 265,010 (+25.2%) Grant
    Chief Operating Officer
    Officer
    Jan 6, 2025 49,800 $0 139,031 (+35.8%) Grant
    Chief Medical Officer
    Officer
    Jan 6, 2025 66,800 $0 173,517 (+38.5%) Grant
    Chief Legal Officer Corp Sec
    Officer
    Jan 3, 2025 11,122 $20,506 97,745 (-11.4%) Sale
    Chief Medical Officer
    Officer
    Jan 3, 2025 10,859 $20,047 106,717 (-10.2%) Sale
    CFO Chief Business Officer
    Officer
    Jan 3, 2025 13,235 $24,367 198,210 (-6.7%) Sale
    Chief Executive Officer
    Director, Officer
    Jan 3, 2025 47,778 $87,873 454,707 (-10.5%) Sale
    Chief Operating Officer
    Officer
    Jan 3, 2025 7,636 $14,225 89,231 (-8.6%) Sale